glp1.how

How GLP-1 medications work, in plain language

Semaglutide and tirzepatide copy hormones your gut already makes after a meal. Here's what those hormones do, why the medications quiet hunger and 'food noise,' what the second hormone in tirzepatide adds, and why 'it slows your stomach' explains both the appetite drop and the nausea.

Updated Jul 16, 2026

When you eat, your gut releases a hormone called GLP-1 (glucagon-like peptide-1). It does a handful of useful things at once: it tells your pancreas to release insulin, it slows how fast your stomach empties, and it signals your brain that you're full. It's part of how a normal meal ends with you pushing the plate away.

GLP-1 medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are lab-made copies of that hormone. Your own GLP-1 breaks down in minutes. These drugs are engineered to survive for about a week, so instead of a brief post-meal blip, you get a steady, around-the-clock version of the same signal. That's the whole idea: not a new sensation, but a familiar one turned up and left on.

What that steady signal actually does

Three effects matter most for weight:

  • Your stomach empties more slowly. Food sits longer, so you feel full sooner during a meal and stay full for hours after. This is the effect you notice first — and, as you'll see, it's also the source of the most common side effect.
  • Appetite drops at the source — in your brain. GLP-1 acts on the parts of the brain that regulate hunger and reward. You're not just fuller; you're less interested in eating in the first place.
  • "Food noise" quiets down. Many people describe a constant background chatter about food — what to eat next, the snack in the cupboard, the second helping. On these medications that chatter often fades. That's not willpower arriving. It's the same appetite circuitry being turned down.

The blood-sugar effect (prompting insulin, which is why these started as diabetes drugs) runs in the background too, but for weight loss the appetite and fullness effects are the ones you feel.

What tirzepatide adds

Semaglutide targets one receptor: GLP-1. Tirzepatide targets two — GLP-1 and a second gut hormone called GIP. That's why it's called a dual agonist. The second target appears to make it more effective on average for weight loss, though it also means a second signaling pathway is involved. Which medication fits you is a conversation for your prescriber; the point here is just that "one hormone vs. two" is the core difference between the two families.

Why this explains the side effects too

Here's the through-line worth holding onto: the same slowed-stomach mechanism that makes you eat less is what makes some people nauseated. Food moving through more slowly is the feature and the side effect at once. It's also why doctors start you on a low dose and raise it gradually — titration — giving your gut time to adjust rather than hitting it with the full effect on day one.

Understanding the mechanism takes the mystery out of a lot of what follows. Less hungry, full faster, quieter food thoughts, occasional queasiness — those aren't four unrelated things. They're one signal, doing what it does.

What it doesn't do

The medication works on calories in — how much you eat. It does nothing directly to protect muscle or keep your metabolism up as you lose weight, which is why nutrition and strength work still matter. It's a powerful tool for the hardest part of weight loss (the constant hunger), not a replacement for the rest of it.

This is general education, not medical advice. Talk to your prescriber about which medication and dose fit your situation.

how-it-worksglp-1semaglutidetirzepatideincretinmechanismtreatment

Was this helpful?

Common questions

Questions people often ask about this topic.

  • How do GLP-1 medications actually make you eat less?

    They copy a gut hormone (GLP-1) your body releases after eating. That signal slows how fast your stomach empties, acts on appetite centers in the brain, and quiets 'food noise' — so you feel full sooner and stay full longer without having to force it.

  • What's the difference between semaglutide and tirzepatide?

    Semaglutide (Ozempic, Wegovy) targets one receptor, GLP-1. Tirzepatide (Mounjaro, Zepbound) is a dual agonist that targets two — GLP-1 and GIP — which tends to make it more effective on average for weight loss. Which one fits you is a conversation for your prescriber.

  • Why do GLP-1 medications cause nausea?

    The same slowed stomach-emptying that helps you eat less is what makes some people nauseated — food moves through more slowly. It's usually worst right after starting or raising a dose, which is why doctors increase the dose gradually.

  • Do GLP-1 medications boost metabolism or just reduce appetite?

    Their main weight effect is on the 'calories in' side — appetite and fullness. They don't directly protect muscle or keep your metabolism up as you lose weight, which is why protein and strength training still matter.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

3Supporting

Related guides

  • Can you boost GLP-1 naturally? How food and lifestyle compare to the medicationsYou can raise your own GLP-1 with protein, fermentable fiber, and exercise — that part is real. What doesn't hold up is the implied equivalence with the medications. Here's what actually nudges your natural GLP-1, why your body clears it in minutes while the drugs hold it for a week, and why "natural boosting" is a foundation rather than a replacement.
  • GLP-1 myths vs. facts: what the media and social feeds get wrongA plain-language, evidence-checked look at the most common claims about GLP-1 medications circulating in the news and on social media — sorting what's false, what's true, and what's genuinely unsettled, with the studies behind each verdict.
  • Switching between diabetes and weight-management dosing of the same drugOzempic and Wegovy — or Mounjaro and Zepbound — share an active ingredient, but they're not interchangeable at a matching dose. Here's why switching between them isn't a simple swap.
  • Understanding your specific drug's dose ladderSemaglutide, tirzepatide, and liraglutide each follow their own titration structure — different starting doses, step sizes, and timing. Here's a general orientation to how they differ, and why you should always confirm specifics with your prescriber.
  • What obesity actually is: history, diagnosis, and why medicine calls it a chronic diseaseThe formula used to diagnose obesity was invented in the 1830s by an astronomer studying populations, not patients — and a lot of what we assume about obesity rests on tools and ideas never designed for the job. Here's what obesity actually is: how the definition moved from moral failing to medical diagnosis, how it's diagnosed today, why major medical bodies classify it as a disease, why 'chronic' is the key word, and where the stigma comes from.
  • New to GLP-1? Start here: your step-by-step learning pathJust starting out with GLP-1 medications, or still deciding? This ordered path walks you from how these medications work through access, side effects, eating well, protecting muscle, tracking progress, and the mental and social side — one step at a time.